The leadership team from Rinn Pharma & Biopharma recently participated in a Research Ireland Innovation Mission to Boston, led by Minister for Further and Higher Education, Research, Innovation and Science, James Lawless. The mission brought together key stakeholders from Ireland's research and innovation ecosystem to explore best practices, strengthen international partnerships, and gain insights from one of the world's leading biotech and innovation hubs.

Representing Rinn were Deputy Director Professor Sarah Hudson and Chief Operating Officer Dr Sarah Hayes. Over the course of a packed and productive week, the delegation engaged with world-class research institutes, universities, innovation centres, and industry leaders across the Greater Boston area.

The programme began with a visit to the Cambridge Innovation Center (CIC), where participants gained first-hand insight into the power of collaborative innovation environments and the role of proximity in fostering entrepreneurship, often referred to as the "bump factor".

The delegation also met with colleagues from the University of Massachusetts system and visited Boston Scientific, where discussions focused on innovation, research translation, and industry-academic collaboration. The visit provided valuable opportunities to exchange ideas and explore future avenues for partnership.

Further engagements included visits to the MIT-IBM Watson AI Lab, where emerging developments in quantum research and advanced computing were showcased, and LabCentral, a leading incubator supporting early-stage biotechnology companies. Thanks to with thanks to Paudie O’Connoe for hosting, followed by a wonderful evening with Education in Ireland where it was fantastic to catch up with colleagues Shane Hegarty, Sinead Chapman and Raghu Peddapatla.

One of the highlights of the week was a visit to the Massachusetts Institute of Technology (MIT), including opportunities to hear from Nobel Laureate Professor Phillip Sharp and engage with renowned innovator Professor Robert Langer. Discussions centred on the foundations of successful innovation ecosystems and the importance of translating research excellence into societal and economic impact. With our colleagues from APC Ltd. And Axelyf.

The mission also included a visit to the Broad Institute of MIT and Harvard, a globally recognised centre for biomedical and genomic research, alongside engagements with Venture Café Cambridge, Nucleate, Northeastern University, MassBio, and the Boston Irish Business Association.

Reflecting on the visit, the Rinn delegation highlighted the exceptional opportunities for learning, collaboration and knowledge exchange, as well as the potential for strengthening connections between Ireland's rapidly growing life sciences sector and leading international innovation ecosystems.

Rinn Pharma & Biopharma extends its thanks to Research Ireland, the Department of Further and Higher Education, Research, Innovation and Science, IDA Ireland, the Consulate General of Ireland in Boston, and all hosts and organisers who contributed to a highly successful and inspiring week.

The mission reinforced the value of international collaboration in driving research excellence, supporting innovation-led growth, and advancing Ireland's position as a global leader in pharmaceutical and biopharmaceutical research.